Monday, September 14, 2026

Daewoong Pharma Signs $1.45 Billion MENA Export Deal for ‘Enavogliflozin,’ Marking Record Global Sales

Daewoong Pharmaceutical's diabetes drug Enblo secures a $1.45 billion deal to enter MENA markets, marking a significant milestone.

K-Beauty Revolution: How BEMT is Transforming Sunscreen in the U.S. Market

K-beauty sunscreens gain FDA approval for bemotrizinol, enhancing UV protection, but U.S. regulations complicate exports.

From Tariffs to Visas: Trump Administration’s Policies Rattle Korean Investors

Trump's management risk affects U.S. businesses, causing delays in Korean investments and visa issues amid rising tensions and tariffs.

Yoo Jin Jeong

Author's Latest

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.